MedPath

The Influence of Overfeeding Different Macronutrients on Whole-body Insulin Sensitivity

Not Applicable
Conditions
Insulin Resistance
Metabolic Disease
Type 2 Diabetes
Glucose Metabolism Disorders
Interventions
Other: High-fat diet
Other: High-carbohydrate diet
Registration Number
NCT03863431
Lead Sponsor
Loughborough University
Brief Summary

This study will investigate the effect of high-carbohydrate vs. high-fat overfeeding (130% of energy requirements) on whole body insulin sensitivity.

Following habitual diet, participants will be randomly allocated to either a high-carbohydrate or a high-fat diet intervention for 14-days. On days 0, 7 and 14 participants will undergo anthropometric and metabolic testing (primarily an oral glucose tolerance test \[OGTT\]).

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • 18-40 years
  • BMI = 18.5-29.9 kg/m2
  • Male or female
  • Physically active (> 3 x 30 min moderate exercise per week)
  • Non-smoker (including the use of vaporisers and e-cigarettes)
  • Healthy (determined by the School's standard health questionnaire)
  • No cardiometabolic or inflammatory illness
Exclusion Criteria
  • Outside of age-range
  • Outside BMI range
  • Inactive (< 3 x 30 min moderate exercise per week)
  • Smoker
  • Taking medication
  • History of cardiometabolic or inflammatory illness
  • Vegetarian/ vegan (as the high-fat diet is based on animal fats)
  • Other dietary restrictions which prevent consumption of the experimental diet
  • Consumption of probiotics within last 3 months (these influence the gut microbiota)
  • Participation in another clinical trial
  • Those with known or suspected food intolerances, allergies or hypersensitivity
  • Women who are known to be pregnant or who are intending to become pregnant over the course of the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High-fat dietHigh-fat dietParticipants will consume a diet rich in fat (approximately 65% of total energy) and low in carbohydrate for 14 days. Measurements will be made at 0, 7 and 14 days.
High-carbohydrate dietHigh-carbohydrate dietParticipants will consume a diet rich in carbohydrate (approximately 70% of total energy) and low in fat for 14 days. Measurements will be made at 0, 7 and 14 days.
Primary Outcome Measures
NameTimeMethod
Whole-body insulin sensitivity indexThe change between pre-, during and post- dietary interventions: Assessed on days 0, 7 and 14

Assessed by oral glucose tolerance test

Secondary Outcome Measures
NameTimeMethod
Indirect calorimetryDay 0, Day 7, Day 14

Measured from expired gas samples

Fasting plasma lipid profile (for example total and HDL cholesterol and TAG concentrations; all measured in mmol/L)Day 0, Day 7, Day 14

Measured in fasting plasma sample by spectrophotometric assay

Body Mass IndexDay 0, Day 7, Day 14

Calculated from height and weight

Fasting plasma glucose concentrationDay 0, Day 7, Day 14

Measured in fasting plasma sample by spectrophotometric assay

Subjective appetite ratingsDay 0, Day 7, Day 14

Measured from visual analogue scale appetite questionnaires

Fasting serum insulin concentrationDay 0, Day 7, Day 14

Measured in fasting serum sample by ELISA

Trial Locations

Locations (1)

School of Sport, Exercise and Health Sciences

🇬🇧

Loughborough, Leicestershire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath